Anti-PD-1 ICIs combined with RT induced significant increases in tumor-antigen specific and memory CD8+ T cells, as well as CD8+/Treg ratio within the peripheral TIME, subsequently leading to significantly amplified local and abscopal antitumor responses (201–204). The gene discussed is CD8A; the disease is neoplasm.